Latest Cancer treatments Stories
--Data Presented by Donald McDonald, UCSF, at the American Association for Cancer Research Meeting 2015-- SAN FRANCISCO, April 20, 2015 /PRNewswire/ -- SillaJen, Inc., a private clinical-stage
DCVax-L and DCVax-Direct Both To Be the Subject of Presentations Today BETHESDA, Md., April 20, 2015 /PRNewswire/ -- Northwest Biotherapeutics, Inc.
- Data support VAL-083's importance as a potential therapy for non-small cell lung cancer (NSCLC), including drug-resistant NSCLC - VANCOUVER, British Columbia and MENLO PARK, Calif.,
-- TRXE-009 distinguished by ability to kill chemo-resistant adult and paediatric brain cancer cells SYDNEY, April 17, 2015 /PRNewswire/ -- US-Australian drug discovery company, Novogen, today
QUÉBEC CITY, April 16, 2015 /PRNewswire/ - Aeterna Zentaris Inc.
OXFORD, England, April 16, 2015 /PRNewswire/ -- Immunocore Limited, a world-leading biotechnology company developing novel biological drugs to treat cancer and other diseases,
SEATTLE, April 15, 2015 /PRNewswire/ -- Adaptive Biotechnologies, the company pioneering Next Generation Sequencing (NGS) applications for cancer immunology, and its collaborators will present
DALLAS, April 10, 2015 /PRNewswire/ -- Lifescienceindustryresearch.com adds Global & USA Cancer Immunotherapy Market Analysis to 2020 a new research report in its store.
NEW YORK, April 10, 2015 /PRNewswire/ -- Delcath Systems, Inc.
- A hairdresser.
More Images (3 images) »